This finding suggested that adiponectin might play a role in the pathogenesis and malignant progression of colonic polyps in prediabetes patients, whereas visfatin might be involved in only the development of colonic polyps and have a limited impact on the progression of the malignant transformation of colonic polyps. Here, ADIPOQ is linked to colon inflammatory polyp.